Treatment of Fungal Sinusitis
Treatment of fungal sinusitis is determined entirely by the specific clinical form: fungal ball requires surgery alone, allergic fungal sinusitis requires surgery plus systemic corticosteroids, chronic invasive disease requires surgery plus antifungal therapy, and acute invasive disease requires urgent surgical debridement plus systemic antifungals (voriconazole or lipid formulation amphotericin B).
Treatment Algorithm by Clinical Form
Fungal Ball (Mycetoma)
- Surgical removal alone is curative 1
- No antifungal therapy required 1, 2
- Enlargement of sinus ostomy may be needed to improve drainage and prevent recurrence 1
- Prognosis is excellent with complete surgical excision 3
Key Point: This is the most common form of fungal sinusitis (96% of non-invasive cases in one series) 4, and overtreating with antifungals is unnecessary and wasteful.
Allergic Fungal Sinusitis (AFRS)
- Primary treatment: Surgical debridement PLUS systemic corticosteroids 5, 2, 6
- Surgery removes allergic mucin and polyps
- Postoperative oral corticosteroids reduce disease activity and prevent recurrence 6
- Monitor total serum IgE levels - changes mirror clinical status and predict recurrence 6
- Aggressive allergy management including immunotherapy 6
- Antifungal agents are NOT recommended 2, 6
Critical Pitfall: Do not confuse AFRS with invasive disease. AFRS patients are atopic with elevated IgE, eosinophilia, and characteristic allergic mucin without tissue invasion. Treating with antifungals instead of corticosteroids is a common error.
Acute Invasive Fungal Sinusitis (AIFRS)
- This is a medical emergency with grave prognosis 3
- Immediate treatment required:
- Occurs almost exclusively in immunocompromised patients (neutropenia, diabetes, transplant recipients) 2, 4
- High mortality despite aggressive treatment 3
Warning: Delay in diagnosis or treatment is often fatal. Any immunocompromised patient with sinusitis symptoms, especially with diabetes and COVID-19 co-infection 4, requires immediate imaging and aggressive intervention.
Chronic Invasive Fungal Sinusitis (CIFRS)
- Combined approach: Surgical debridement PLUS systemic antifungal therapy 1, 2, 3
- Voriconazole is preferred antifungal 1
- Alternative: Lipid formulation amphotericin B 1
- More indolent course than acute invasive disease 2
- Risk of complications including vision loss from orbital invasion 3
Chronic Granulomatous Fungal Sinusitis (CGFRS)
- Treatment similar to chronic invasive disease
- Surgery plus systemic antifungals 1
- Long-term follow-up required
Specific Antifungal Recommendations
When antifungals are indicated (invasive forms only):
First-line: Voriconazole 1
- Preferred for CNS extension risk
- Strong recommendation with moderate-quality evidence
Alternative: Lipid formulation amphotericin B 1
- Reserved for voriconazole intolerance or refractory disease
- Used in critically ill patients
Duration: Continue until complete resolution, minimum 3 months for invasive disease 1
Diagnostic Considerations That Guide Treatment
The treatment algorithm depends on accurate classification:
- CT imaging: Best for detecting bone destruction and evaluating paranasal sinuses 7, 5
- MRI: Superior for detecting tissue invasion and CNS extension 7, 5
- Histopathology: Essential to differentiate invasive from non-invasive forms 5, 4
- Look for fungal hyphae within mucosa, submucosa, bone, or blood vessels (invasive)
- Absence of tissue invasion with allergic mucin and eosinophils (AFRS)
- Nasal endoscopy: Should be performed in all suspected cases 7
Common Pitfalls to Avoid
- Do not give antifungals for fungal ball - surgery alone is curative
- Do not give antifungals for AFRS - corticosteroids are the medical treatment
- Do not delay surgery in invasive disease - combined surgical and medical approach is mandatory
- Do not miss immunocompromised status - diabetes with COVID-19 is now the most common comorbidity 4
- Do not rely on culture alone - histopathology has 90% sensitivity and 96% specificity for Aspergillus 4